Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal
In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI
Bob Young To Head Centers & Community Oncology; Meyers Takes Medicine Branch
Gallo To Say, For Now, DeVita Says: Core Grants Face Big Cut
DCE Board Approves Recompetition Concepts
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
